385 related articles for article (PubMed ID: 17442991)
1. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Clin Oncol; 2007 Apr; 25(12):1498-504. PubMed ID: 17442991
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis: An emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia.
Aricò M; Boccalatte MF; Silvestri D; Barisone E; Messina C; Chiesa R; Santoro N; Tamaro P; Lippi A; Gallisai D; Basso G; De Rossi G;
Haematologica; 2003 Jul; 88(7):747-53. PubMed ID: 12857552
[TBL] [Abstract][Full Text] [Related]
3. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma.
Karimova EJ; Rai SN; Howard SC; Neel M; Britton L; Pui CH; Kaste SC
J Clin Oncol; 2007 Apr; 25(12):1525-31. PubMed ID: 17442995
[TBL] [Abstract][Full Text] [Related]
4. [MRI of aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukemia].
Engelbrecht V; Scherer A; Bruder M; Körholz D; Mödder U
Rofo; 2000 Apr; 172(4):336-41. PubMed ID: 10961217
[TBL] [Abstract][Full Text] [Related]
5. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
[TBL] [Abstract][Full Text] [Related]
6. Impaired dexamethasone-related increase of anticoagulants is associated with the development of osteonecrosis in childhood acute lymphoblastic leukemia.
te Winkel ML; Appel IM; Pieters R; van den Heuvel-Eibrink MM
Haematologica; 2008 Oct; 93(10):1570-4. PubMed ID: 18698082
[TBL] [Abstract][Full Text] [Related]
7. [Is there a risk of steroid-induced adrenal deficit after induction treatment of acute lymphoblastic leukemia?].
Bélien-Pallet V; Cabrol S; Fasola S; Petit A; Landman-Parker J; Auvrignon A; Leverger G
Arch Pediatr; 2010 Dec; 17(12):1637-44. PubMed ID: 20943354
[TBL] [Abstract][Full Text] [Related]
8. No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol.
Igarashi S; Manabe A; Ohara A; Kumagai M; Saito T; Okimoto Y; Kamijo T; Isoyama K; Kajiwara M; Sotomatsu M; Sugita K; Sugita K; Maeda M; Yabe H; Kinoshita A; Kaneko T; Hayashi Y; Ikuta K; Hanada R; Tsuchida M
J Clin Oncol; 2005 Sep; 23(27):6489-98. PubMed ID: 16170158
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)--experiences from trial ALL-BFM 95.
Bürger B; Beier R; Zimmermann M; Beck JD; Reiter A; Schrappe M
Pediatr Blood Cancer; 2005 Mar; 44(3):220-5. PubMed ID: 15514916
[TBL] [Abstract][Full Text] [Related]
10. Use of bisphosphonates for the treatment of osteonecrosis as a complication of therapy for childhood acute lymphoblastic leukaemia (ALL).
Kotecha RS; Powers N; Lee SJ; Murray KJ; Carter T; Cole C
Pediatr Blood Cancer; 2010 Jul; 54(7):934-40. PubMed ID: 20127847
[TBL] [Abstract][Full Text] [Related]
11. L-asparaginase as a marker of chemotherapy dose modification in children with acute lymphoblastic leukemia.
Baillargeon J; Langevin AM; Lewis M; Thomas PJ; Mullins J; Dugan J; Pollock BH
Cancer; 2005 Dec; 104(12):2858-61. PubMed ID: 16288492
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for leukemic induction failure in children with acute lymphoblastic leukemia and outcome after salvage therapy: the FRALLE 93 study.
Oudot C; Auclerc MF; Levy V; Porcher R; Piguet C; Perel Y; Gandemer V; Debre M; Vermylen C; Pautard B; Berger C; Schmitt C; Leblanc T; Cayuela JM; Socie G; Michel G; Leverger G; Baruchel A
J Clin Oncol; 2008 Mar; 26(9):1496-503. PubMed ID: 18349402
[TBL] [Abstract][Full Text] [Related]
13. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
14. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis in children treated for lymphoma or solid tumors.
Niinimäki RA; Harila-Saari AH; Jartti AE; Seuri RM; Riikonen PV; Pääkkö EL; Möttönen MI; Lanning M
J Pediatr Hematol Oncol; 2008 Nov; 30(11):798-802. PubMed ID: 18989155
[TBL] [Abstract][Full Text] [Related]
16. Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.
Nakamura J; Saisu T; Yamashita K; Suzuki C; Kamegaya M; Takahashi K
Arthritis Rheum; 2010 Feb; 62(2):609-15. PubMed ID: 20112393
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
[TBL] [Abstract][Full Text] [Related]
18. Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia.
Elmantaser M; Stewart G; Young D; Duncan R; Gibson B; Ahmed SF
Arch Dis Child; 2010 Oct; 95(10):805-9. PubMed ID: 20576660
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
Klimza MJ; Sońta-Jakimczyk DJ
Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
[TBL] [Abstract][Full Text] [Related]
20. Bony morbidity in children treated for acute lymphoblastic leukemia.
Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
